首页 | 本学科首页   官方微博 | 高级检索  
     

肺癌筛查的卫生经济学评价研究
引用本文:张温馨,潘宇,李峒作,王亮,马原,寇静恬,唐文祥,迟航. 肺癌筛查的卫生经济学评价研究[J]. 中国卫生经济, 2023, 42(8): 78-81
作者姓名:张温馨  潘宇  李峒作  王亮  马原  寇静恬  唐文祥  迟航
作者单位:哈尔滨医科大学附属第一医院 哈尔滨 150001
摘    要:目的:对肺癌筛查进行成本一效果分析,评价肺癌筛查的经济性。方法:构建肺癌筛查决策树模型,对肺癌筛查及不筛查两种策略进行投入产出分析,评价两种策略的成本与健康产出,并进行增量成本一效果分析,判断肺癌筛查策略的经济性。结果:肺癌筛查策略与不筛查策略相比,每多获得1个寿命年的成本为93 153元。结论:根据WHO推荐阈值,在人群中实施肺癌筛查是具有成本一效果的,应在人群中积极推广肺癌筛查。

关 键 词:肺癌筛查  成本-效果分析  决策树模型
收稿时间:2023-05-08

Research on the Health Economic Evaluation of Lung Cancer Screening
Zhang Wenxin,Pan Yu,Li Dongzuo,Wang Liang,Ma Yuan,Kou Jingtian,Tang Wenxiang,Chi Hang. Research on the Health Economic Evaluation of Lung Cancer Screening[J]. Chinese Health Economics, 2023, 42(8): 78-81
Authors:Zhang Wenxin  Pan Yu  Li Dongzuo  Wang Liang  Ma Yuan  Kou Jingtian  Tang Wenxiang  Chi Hang
Affiliation:The First Affiliated Hospital of Harbin Medical University, Harbin, 150001 , China
Abstract:Objective: Conduct a cost-effectiveness analysis of lung cancer screening to evaluate the economic viability of lung cancer screening. Methods: A decision tree model for lung cancer screening was constructed to analyze the input-output of lung can- cer screening and non-screening strategies, and to evaluate the cost and health outcomes of these two strategies. Incremental cost ef- fectiveness analysis was performed to determine the economics of lung cancer screening strategies. Results: The cost of gaining an additional year of life through lung cancer screening strategy compared to non-screening strategy is 93 153 yuan. Conclusion: Ac- cording to the WHO recommended threshold, implementing lung cancer screening in the population is cost-effective and should be actively promoted.
Keywords:
点击此处可从《中国卫生经济》浏览原始摘要信息
点击此处可从《中国卫生经济》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号